Annual Review of Immunology,
Journal Year:
2021,
Volume and Issue:
39(1), P. 251 - 277
Published: Feb. 9, 2021
The
immune
system
of
the
central
nervous
(CNS)
consists
primarily
innate
cells.
These
are
highly
specialized
macrophages
found
either
in
parenchyma,
called
microglia,
or
at
CNS
interfaces,
such
as
leptomeningeal,
perivascular,
and
choroid
plexus
macrophages.
While
they
were
thought
phagocytes,
their
function
extends
well
beyond
simple
removal
cell
debris
during
development
diseases.
Brain-resident
cells
to
be
plastic,
long-lived,
host
an
outstanding
number
risk
genes
for
multiple
pathologies.
As
a
result,
now
considered
most
suitable
targets
modulating
Additionally,
recent
single-cell
technologies
enhanced
our
molecular
understanding
origins,
fates,
interactomes,
functional
statesduring
health
perturbation.
Here,
we
review
current
state
challenges
myeloid
biology
treatment
options
related
Cell Reports,
Journal Year:
2020,
Volume and Issue:
30(5), P. 1271 - 1281
Published: Feb. 1, 2020
Microglia
are
resident
immune
cells
in
the
central
nervous
system
(CNS)
that
capable
of
carrying
out
prominent
and
various
functions
during
development
adulthood
under
both
homeostatic
disease
conditions.
Although
microglia
traditionally
thought
to
be
heterogeneous
populations,
which
potentially
allows
them
achieve
a
wide
range
responses
environmental
changes
for
maintenance
CNS
homeostasis,
lack
unbiased
high-throughput
methods
assess
heterogeneity
has
prevented
study
spatially
temporally
distributed
subsets.
The
recent
emergence
novel
single-cell
techniques,
such
as
cytometry
by
time-of-flight
mass
spectrometry
(CyTOF)
RNA
sequencing,
enabled
scientists
overcome
limitations
reveal
surprising
context-dependent
microglia.
In
this
review,
we
summarize
current
knowledge
about
spatial,
temporal,
functional
diversity
development,
mice
humans.
Nature,
Journal Year:
2022,
Volume and Issue:
603(7903), P. 934 - 941
Published: Feb. 7, 2022
Abstract
Diffuse
intrinsic
pontine
glioma
(DIPG)
and
other
H3K27M-mutated
diffuse
midline
gliomas
(DMGs)
are
universally
lethal
paediatric
tumours
of
the
central
nervous
system
1
.
We
have
previously
shown
that
disialoganglioside
GD2
is
highly
expressed
on
cells
demonstrated
promising
preclinical
efficacy
GD2-directed
chimeric
antigen
receptor
(CAR)
T
2
,
providing
rationale
for
a
first-in-human
phase
I
clinical
trial
(NCT04196413).
Because
CAR
cell-induced
brainstem
inflammation
can
result
in
obstructive
hydrocephalus,
increased
intracranial
pressure
dangerous
tissue
shifts,
neurocritical
care
precautions
were
incorporated.
Here
we
present
experience
from
first
four
patients
with
DIPG
or
spinal
cord
DMG
treated
GD2-CAR
at
dose
level
(1
×
10
6
per
kg
administered
intravenously).
Patients
who
exhibited
benefit
eligible
subsequent
cell
infusions
intracerebroventricularly
3
Toxicity
was
largely
related
to
location
tumour
reversible
intensive
supportive
care.
On-target,
off-tumour
toxicity
not
observed.
Three
radiographic
improvement.
Pro-inflammatory
cytokine
levels
plasma
cerebrospinal
fluid.
Transcriptomic
analyses
65,598
single
products
fluid
elucidate
heterogeneity
response
between
participants
administration
routes.
These
early
results
underscore
promise
this
therapeutic
approach
DMG.
Nature,
Journal Year:
2023,
Volume and Issue:
620(7973), P. 374 - 380
Published: Aug. 2, 2023
Low-grade
inflammation
is
a
hallmark
of
old
age
and
central
driver
ageing-associated
impairment
disease1.
Multiple
factors
can
contribute
to
inflammation2;
however,
the
molecular
pathways
that
transduce
aberrant
inflammatory
signalling
their
impact
in
natural
ageing
remain
unclear.
Here
we
show
cGAS-STING
pathway,
which
mediates
immune
sensing
DNA3,
critical
chronic
functional
decline
during
ageing.
Blockade
STING
suppresses
phenotypes
senescent
human
cells
tissues,
attenuates
ageing-related
multiple
peripheral
organs
brain
mice,
leads
an
improvement
tissue
function.
Focusing
on
brain,
reveal
activation
triggers
reactive
microglial
transcriptional
states,
neurodegeneration
cognitive
decline.
Cytosolic
DNA
released
from
perturbed
mitochondria
elicits
cGAS
activity
microglia,
defining
mechanism
by
engaged
brain.
Single-nucleus
RNA-sequencing
analysis
microglia
hippocampi
gain-of-function
mouse
model
demonstrates
engagement
sufficient
direct
states
leading
bystander
cell
inflammation,
neurotoxicity
impaired
memory
capacity.
Our
findings
establish
pathway
as
blockade
potential
strategy
halt
neurodegenerative
processes
age.
Molecular Psychiatry,
Journal Year:
2019,
Volume and Issue:
25(2), P. 351 - 367
Published: Nov. 26, 2019
Abstract
Microglia
have
been
recently
shown
to
manifest
a
very
interesting
phenotypical
heterogeneity
across
different
regions
in
the
mammalian
central
nervous
system
(CNS).
However,
underlying
mechanism
and
functional
meaning
of
this
phenomenon
are
currently
unclear.
Baseline
diversities
adult
microglia
their
cell
number,
cellular
subcellular
structures,
molecular
signature
as
well
relevant
functions
discovered.
But
recent
transcriptomic
studies
using
bulk
RNAseq
single-cell
produced
conflicting
results
on
region-specific
signatures
microglia.
It
is
highly
speculative
whether
such
spatial
contributes
varying
sensitivities
individual
same
physiological
pathological
signals
CNS
regions,
hence
underlie
relevance
for
disease
development.
This
review
aims
thoroughly
summarize
up-to-date
knowledge
specific
topic
provide
some
insights
potential
mechanisms,
starting
from
microgliogenesis.
Understanding
regional
context
diverse
neighboring
neurons
other
glia
may
an
important
clue
future
development
innovative
therapies
neuropsychiatric
disorders.